MENU
LXRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lexicon Pharmaceuticals (LXRX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

LXRX is expected to report earnings to fall 34.44% to -11 cents per share on March 12

Lexicon Pharmaceuticals LXRX Stock Earnings Reports
Q4'24
Est.
$-0.12
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.20
Q4'23
Beat
by $0.02
The last earnings report on November 12 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 5.04M shares outstanding, the current market capitalization sits at 265.41M.
View a ticker or compare two or three
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in discovery and development of breakthrough treatments for human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2445 Technology Forest Boulevard
Phone
+1 281 863-3000
Employees
285
Web
https://www.lexpharma.com